[HTML][HTML] Construction and validation of an immune-based prognostic model for pancreatic adenocarcinoma based on public databases

M Mao, H Ling, Y Lin, Y Chen, B Xu, R Zheng - Frontiers in Genetics, 2021 - frontiersin.org
Background Pancreatic adenocarcinoma (PAAD) is a highly lethal and aggressive tumor
with poor prognoses. The predictive capability of immune-related genes (IRGs) in PAAD has …

Construction and Validation of an Immune-Based Prognostic Model for Pancreatic Adenocarcinoma Based on Public Databases

M Mao, H Ling, Y Lin, Y Chen, B Xu… - … Tools (and Web Server …, 2022 - books.google.com
Background: Pancreatic adenocarcinoma (PAAD) is a highly lethal and aggressive tumor
with poor prognoses. The predictive capability of immune-related genes (IRGs) in PAAD has …

Construction and Validation of an Immune-Based Prognostic Model for Pancreatic Adenocarcinoma Based on Public Databases

M Mao, H Ling, Y Lin, Y Chen, B Xu… - Frontiers in …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Pancreatic adenocarcinoma (PAAD) is a highly lethal and aggressive tumor
with poor prognoses. The predictive capability of immune-related genes (IRGs) in PAAD has …

Construction and Validation of an Immune-Based Prognostic Model for Pancreatic Adenocarcinoma Based on Public Databases.

M Mao, H Ling, Y Lin, Y Chen, B Xu, R Zheng - Frontiers in Genetics, 2021 - europepmc.org
Background Pancreatic adenocarcinoma (PAAD) is a highly lethal and aggressive tumor
with poor prognoses. The predictive capability of immune-related genes (IRGs) in PAAD has …

[HTML][HTML] Construction and Validation of an Immune-Based Prognostic Model for Pancreatic Adenocarcinoma Based on Public Databases

M Mao, H Ling, Y Lin, Y Chen, B Xu… - Frontiers in Genetics, 2021 - ncbi.nlm.nih.gov
Background Pancreatic adenocarcinoma (PAAD) is a highly lethal and aggressive tumor
with poor prognoses. The predictive capability of immune-related genes (IRGs) in PAAD has …